971-P: "Take a Chance on Me"—A Trial of Automated Insulin Delivery in Those Who Historically Declined Pump Therapy

Introduction 1%. Post-trial, A1c (7.3-8.6%), end-trial TIR 46-67%, and post-trial hypoglycemia 2%. Post-survey, comments included “Having the ability to feel more ‘normal’ having access to my sugars all the time without having to finger prick or scan⋯” “I didn’t have to think too much other than carb counting⋯” “Being able to have insulin all the time without giving a needle is great.” Conclusion: This study demonstrates that the advancement in AID should enable a policy change to allow ubiquitous usage to those with T1D for best standard of care. Disclosure C. Ibrahim: None.